Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Diseases of the Nervous System

Explore clinical trials studying Autoimmune Diseases of the Nervous System. Study availability and eligibility vary by location and protocol.

3,227 public trials 541 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Diseases of the Nervous System trial results

Completed

Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)

NCT00395317

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • GSK Investigational Site Camperdown, New South Wales, Australia
  • GSK Investigational Site Woodville, South Australia, Australia
  • GSK Investigational Site Fitzroy, Victoria, Australia
  • GSK Investigational Site Parkville, Victoria, Australia
View all 79 locations
View Trial Details
Completed

Sensori-motor Integration Training in Multiple Sclerosis

NCT01040117

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • S.S.O. di Riabilitazione dell'Ospedale Policlinico Verona, Italy
  • Section of Clinical Neurology, Department Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona, Verona, Italy Verona, Italy
View Trial Details
Completed

Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis

NCT00241254

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +9 more
Locations
  • CH de la Cote Basque Bayonne, France
  • CHU Besançon Besançon, France
  • Hôpital Pellegrin, Département de neurologie Bordeaux, France
  • CHU Caen Caen, France
View all 26 locations
View Trial Details
Completed

BENEFIT Extension Study

NCT00544037

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Many Locations, Austria
  • Many Locations, Belgium
  • Many Locations, Canada
  • Many Locations, Czechia
View all 18 locations
View Trial Details
Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis

NCT00654927

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • USC, Keck School of Medicine Health Care Consultation Center Los Angeles, California, United States
  • Shepherd Center Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View all 22 locations
View Trial Details
Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial

NCT00649792

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • HOPE Research Institute Phoenix, Arizona, United States
  • Neurological Associates Fayetteville, Arkansas, United States
  • Alta Bates Summit Medical Center - Research and Education Institute Berkeley, California, United States
View all 42 locations
View Trial Details
Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

NCT00648908

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • USC, Keck School of Medicine Health Care Consultation Center Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Shepherd Center Atlanta, Georgia, United States
View all 32 locations
View Trial Details

Related conditions